a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
ab
Ablevia develops a new class of infusible therapeutics to selectively remove harmful and disease-causing antibodies. These therapeutics can be readily adapted to target unwanted antibodies in rare diseases or in conditions with unmet clinical needs. Founded in 2018 at the Vienna Biocenter Campus, Ablevia focuses on IP generation and preclinical research and development.
Acapsia Pharma Production GmbH specializes in production outsourcing in the pharmaceutical sector, i.e. in contract manufacturing and contract manufacturing of cosmetics, nutritional supplements and medical devices. We produce private labels of well-known companies such as cosmetics, dietary supplements and medical products in different shapes and packaging. Our production facility in Grafenwörth (Lower Austria) complies with international manufacturing standards in all aspects. www.acapsia.com
The AGRANA Research
Allcyte is a pioneer in the field of functional precision oncology. The company provides actionable data on the activity of drug candidates directly in live tissue samples of human cancer patients to support strategic R
OUR MISSION: TO SERVE PATIENTS AMGEN harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients. Our investment in R&D has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
Angios is an Austrian biotechnology company, specialising in cell based research We target vascular therapies
AOP Health is a European pioneer in developing integrated therapies for rare diseases and in critical care. Over the past 25 years, the company has expanded its reach with subsidiaries and representative offices throughout Europe and the Middle East. From the headquarters in Vienna AOP Health covers the full product lifecycle: nonclinical, clinical, pharmaceutical research and development, regulatory, medical, pharmacovigilance, quality and supply chain, market access, and distribution.
APEIRON Biologics AG at a glance: APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. APEIRON Biologics´ projects and technologies are based on a strong patent portfolio and partnerships with leading pharmaceutical companies and academic institutions.
APEPTICO Forschung und Entwicklung GmbH is a privately-held development stage biotechnology company in Vienna, Austria, developing peptide-based products targeting life-threatening pulmonary diseases.